AssetMark Inc’s BlackRock Health Sciences Trust BME Stock Holding History

AssetMark Inc’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.3K	Buy	+52	New	+$2.3K	﹤0.01%	3011

Other funds holding BME

Nova R Wealth Overland Park, Kansas $341M AUM 12.71% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.29B AUM 13.16% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Alessandra Capital Management Torrance, California $142M AUM 42.73% 1-Year Est. Return

Smith Asset Management Chiefland, Florida $123M AUM 1.3% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

HBK Sorce Advisory Erie, Pennsylvania $5.18B AUM 12.38% 1-Year Est. Return

AssetMark Inc's BME Position: Q3 2026 in Review

AssetMark Inc opened a new position in BlackRock Health Sciences Trust (BME) in Q3 2026: 52 shares worth $2.3K. The stake represents ﹤0.01% of the portfolio and ranks #3011 among its holdings.

40 funds tracked by Wall St. Rank hold BME as of Q3 2026.

AssetMark Inc held 52 shares of BlackRock Health Sciences Trust worth $2.3K as of Q3 2026.
BlackRock Health Sciences Trust was a new AssetMark Inc position in Q3 2026.
BlackRock Health Sciences Trust made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3011 holding.
40 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.